INTERNATIONAL PATENT: QUBIT PHARMACEUTICALS FILES APPLICATION FOR "NEW ACYLSULFONAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER"

GENEVA, April 28 -- QUBIT PHARMACEUTICALS (29 RUE DU FAUBOURG SAINT-JACQUES75014 PARIS) filed a patent application (PCT/EP2025/079829) for "NEW ACYLSULFONAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER" on Oct 15, 2025. With publication no. WO/2026/082829, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EL HAGE, Krystel (c/o Qubit Pharmaceuticals29 rue du Faubourg Saint Jacques75014 Paris), NICOLAÏ, Eric (c/o Qubit Pharmaceuticals29 rue du Faubourg Saint Jacques75014 Paris)

Abstract: The present disclosu...